Advertisement

Topics

#news #biotech Sellas snags Nasdaq listing in reverse merger with Galena

09:36 EDT 8 Aug 2017 | Biotech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sellas snags Nasdaq listing in reverse merger with Galena .Sellas Life Sciences has snagged itself a Nasdaq listing by merging with Galena Biopharma. The deal gives Sellas a … Continue reading

Cet article #news #biotech Sellas snags Nasdaq listing in reverse merger with Galena est apparu en premier sur Biotech 365.

Original Article: #news #biotech Sellas snags Nasdaq listing in reverse merger with Galena

NEXT ARTICLE

More From BioPortfolio on "#news #biotech Sellas snags Nasdaq listing in reverse merger with Galena"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...